Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fludarabine/cyclophosphamide with or without Rituximab in untreated mantle cell lymphoma
2006-001965-41Phase 3Completed
- Sponsor
- University College London
- Start
- Apr 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of rituximab in mantle cell lymphoma (MCL) (2 arms), sponsored by University College London. Primary endpoint: Overall survival. Started Apr 2006; status: completed.
02
Drugs
rituximab
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on 2006-001965-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001965-41.